RIVASTIGMINE
rivastigmine 3 mg capsule, 56
RIVASTIGMINE (8498G)
8498G
Body System:
Manner of administration:Oral
Restriction
Indication: Mild to moderately severe Alzheimer disease
Treatment phase: Initial
Restriction
Indication: Mild to moderately severe Alzheimer disease
Treatment phase: Initial
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 56 | # of repeats: 5 | DPMQ: $83.29 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Exelon | |||||